<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02545569</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-Nr. 2014-0459</org_study_id>
    <nct_id>NCT02545569</nct_id>
  </id_info>
  <brief_title>Evaluation of New Custom Made Hearing Product Technology and Shell Modification</brief_title>
  <acronym>CPS</acronym>
  <official_title>Evaluation of New Custom Made Hearing Product Technology and Shell Modification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phonak AG, Switzerland</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phonak AG, Switzerland</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this evaluation is to receive the greatest benefit of new custom made hearing
      product technology and shell modification for the end customer and to continual improve the
      custom made hearing products.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a controlled, single blinded comparative study which is conducted monocentric at
      Phonak Headquarters in Staefa.

      The purpose of the studies is to evaluate the strengths and weaknesses of new custom product
      development in comparison to existing/old products. The results should promote the custom
      product development, to provide a maximum of benefit and wearing comfort to the hearing aid
      user.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 6, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Objective measurement of speech intelligibility related to the intervention.</measure>
    <time_frame>5 years</time_frame>
    <description>SNR (speech to noise ratio) in decibel.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective measurement of the transfer function related to the intervention.</measure>
    <time_frame>5 years</time_frame>
    <description>REM (real ear measurement) in decibel.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective measurement from the position of the outer ear related to the test subject.</measure>
    <time_frame>5 years</time_frame>
    <description>Measurement in degree.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective measurement from the size of the outer ear related to the test subject.</measure>
    <time_frame>5 years</time_frame>
    <description>Measurement in micron.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective measurement of humidity in the ear canal related to the test subject and the intervention.</measure>
    <time_frame>5 years</time_frame>
    <description>Measurement in percent.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective measurement of temperature in the ear canal related to the test subject and the intervention.</measure>
    <time_frame>5 years</time_frame>
    <description>Measurement in degree centigrade.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective rating of the intervention via questionnaire.</measure>
    <time_frame>5 years</time_frame>
    <description>Ordinal scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Hearing Loss, Bilateral or Unilateral</condition>
  <arm_group>
    <arm_group_label>Hearing Device Type A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the ear (ITE) hearing aid, 1-3 weeks wearing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hearing Device Type B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the ear (ITE) hearing aid, 1-3 weeks wearing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hearing aid (MD class IIa) - ITE, BTE, RIC</intervention_name>
    <description>Hearing aid means any wearable instrument or device designed for, offered for the purpose of, or represented as aiding persons with or compensating for, impaired hearing.</description>
    <arm_group_label>Hearing Device Type A</arm_group_label>
    <arm_group_label>Hearing Device Type B</arm_group_label>
    <other_name>hearing accessory (MD class I) - DM systems, FM systems, remote control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Only adult participants between 18 and 99 years

          -  lnformed Consent as documented by signature (Appendix lnformed Consent Form)

          -  Ability to fill in a questionnaire conscientious

          -  Healthy outer ear (w/o previous surgical procedures)

        Exclusion Criteria:

          -  Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to
             the investigational product,

          -  Limited mobility and not in the position to attend weekly appointments

          -  Limited ability to describe listening impressions/experiences and the use of the
             hearing aid

          -  lnability to produce a reliable hearing test result when pure tone audiometry is
             attempted by the audiologist

          -  Massively limited dexterity

          -  Psychological problems

          -  Central hearing problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jana-Kosima Schwarzlos, B.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Switzerland, Sonova AG, CH-8712 Staefa, Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jana-Kosima Schwarzlos, B.Sc.</last_name>
    <phone>+41 58 928 0101</phone>
    <email>JanaKosima.Schwarzlos@sonova.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sonova AG</name>
      <address>
        <city>Stäfa</city>
        <state>Zürich</state>
        <zip>8712</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Jana-Kosima Schwarzlos</last_name>
      <phone>0041 58 928 0101</phone>
      <email>JanaKosima.Schwarzlos@sonova.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 19, 2015</study_first_submitted>
  <study_first_submitted_qc>September 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2015</study_first_posted>
  <last_update_submitted>August 28, 2019</last_update_submitted>
  <last_update_submitted_qc>August 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Hearing Loss, Bilateral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

